Legend Biotech (LEGN) Inventory Average (2020 - 2025)
Legend Biotech (LEGN) posted Inventory Average of $30.6 million for Q4 2025, down 5.54% on a QoQ basis from $32.4 million in Q3 2025, and up 28.95% year-over-year from $23.7 million in Q4 2024.
Legend Biotech (LEGN) has 6 years of Inventory Average data on file, last reported at $30.6 million in Q4 2025.
- In Q4 2025, Inventory Average rose 28.95% year-over-year to $30.6 million; the TTM figure through Dec 2025 stood at $30.6 million (up 28.95% YoY), while the FY2025 annual figure was $28.0 million, up 29.0% from the prior year.
- Inventory Average retreated to $30.6 million in Q4 2025, from $32.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $33.3 million in Q2 2025 and bottomed at $1898.5 in Q2 2021.
- A 5-year average of $16.2 million and a median of $18.7 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2021 — Inventory Average soared 51320.94% — and 2024, when it gained 26.71%.
- Year by year, Inventory Average stood at $1.7 million in 2021, then soared by 37.27% to $2.3 million in 2022, then jumped by 706.35% to $18.7 million in 2023, then gained by 26.71% to $23.7 million in 2024, then rose by 28.95% to $30.6 million in 2025.
- The last three Inventory Average figures came in at $30.6 million (Q4 2025), $32.4 million (Q3 2025), and $33.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.59 Mn |
| Sep 30, 2025 | 32.39 Mn |
| Jun 30, 2025 | 33.26 Mn |
| Mar 31, 2025 | 27.42 Mn |
| Dec 31, 2024 | 23.72 Mn |
| Sep 30, 2024 | 21.21 Mn |
| Jun 30, 2024 | 20.51 Mn |
| Mar 31, 2024 | 20.79 Mn |
| Dec 31, 2023 | 18.72 Mn |
| Sep 30, 2023 | 16.61 Mn |
| Jun 30, 2023 | 13.69 Mn |
| Mar 31, 2023 | 11.27 Mn |
| Mar 31, 2022 | 2.32 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 30, 2021 | 817,850.00 |
| Jun 30, 2021 | 1,898.50 |
| Mar 31, 2021 | 901,048.50 |
| Dec 31, 2020 | 900,756.50 |
| Sep 30, 2020 | 1,590.50 |